Ear Research stock Rec

The chart shows the growth of an initial investment of $10,000 in Ear Research stock Rec, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Mar 19, 2018, Ear Research stock Rec's average daily return is +0.07%, while the average monthly return is +1.40%. At this rate, your investment would double in approximately 4.2 years.

Historically, 67% of months were positive and 33% were negative. The best month was Apr 2020 with a return of +10.7%, while the worst month was Dec 2018 at -8.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.

On a daily basis, Ear Research stock Rec closed higher 55% of trading days. The best single day was Mar 13, 2020 with a return of +8.2%, while the worst single day was Mar 16, 2020 at -9.9%.

Ear Research stock Rec has an annualized alpha of 6.24%, beta of 0.89, and R² of 0.94 versus S&P 500 Index. Calculated based on daily prices since March 19, 2018.

• This portfolio captured 103.99% of S&P 500 Index gains but only 82.31% of its losses — a favorable profile for investors.
• This portfolio generated an annualized alpha of 6.24% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
• With beta of 0.89 and R² of 0.94, this portfolio moves broadly in line with S&P 500 Index — much of its variation is explained by market exposure rather than independent behavior.

Ear Research stock Rec has an expense ratio of 0.03%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Ear Research stock Rec ranks 35 for risk / return — below 35% of portfolios on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Ear Research stock Rec Sharpe ratios as of Apr 7, 2026 (values are recalculated daily):

• 1-Year: 1.55
• 5-Year: 0.93
• All Time: 0.96

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.63 to 2.54, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of Ear Research stock Rec compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Ear Research stock Rec provided a 1.37% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Ear Research stock Rec. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ear Research stock Rec was 26.33%, occurring on Mar 23, 2020. Recovery took 52 trading sessions.

The current Ear Research stock Rec drawdown is 6.95%.

The chart below shows the rolling one-month volatility.